Description: OAB treatment | GEMTESA | Urovant Sciences: Successful Launch of First Commercial Product Enables Company’s Growth and Evolution in Addressing Unmet Needs in Urology | CEO Interviews 2021 | Medical Companies
therapies for urological conditions gemtesa for adult patients with oab vibegron treatment for urge urinary incontinence treatments for urinary leakage episodes treatments urinary urgency treatment for the need to urinate right away treatment for frequent urination improve overactive bladder symptoms reduce urge to go feelings
© CEOCFO Magazine - All rights reserved
CEOCFO Magazine, PO Box 340 Palm Harbor, FL 34682- 0340 Phone: 727- 480- 7070
Email: [email protected]